Company · CIK 0001824893 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
Surrozen, Inc./DE · SRZN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 22, 2026 SForm 4 → | Jul 24, 9:00 pm EDT | TCG Crossover GP II, LLC +410% Owner | 325,000 | $21.25 | $6,906,250 | 574,047 | −36.1% | |
| Jun 15, 2026 AForm 4 → | Jun 16, 4:55 pm EDT | Andrew Pedrum MalekiChief Financial Officer | 607 | $19.01 | $11,539 | 607 | — | |
| Jun 15, 2026 AForm 4 → | Jun 16, 4:51 pm EDT | Yang LiExec. Vice President, Research | 1,666 | $8.11 | $13,511 | 18,882 | — | |
| Jun 15, 2026 AForm 4 → | Jun 16, 4:47 pm EDT | Charles O WilliamsChief Operating Officer | 1,666 | $8.11 | $13,511 | 18,237 | — | |
| Jun 15, 2026 AForm 4 → | Jun 16, 4:44 pm EDT | Craig C ParkerChief Executive Officer, Director | 1,622 | $8.11 | $13,154 | 18,175 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.